Dr. Tejashri Purohit-Sheth is currently the Director of the Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT) in the Office of Tissues and Advanced Therapies (OTAT) in the Center for Biologics Evaluation and Research at the Food and Drug Administration. She provides supervisory oversight for the clinical and pharmacology/toxicology review of submissions to OTAT. She previously served as the Clinical Deputy Director in DAGRID/ODE/CDRH/FDA as well as Acting Division Director and Branch Chief in Office of Scientific Investigation overseeing Bioresearch Monitoring in CDER/FDA and as a Medical Officer in the Division of Pulmonary and Allergy Products (CDER/FDA).
She completed an Internal Medicine Residency at Naval Medical Center Portsmouth followed by a fellowship in Allergy/Immunology at Walter Reed Army Medical Center. Following fellowship, she took over as Service Chief of the Allergy/Immunology clinic at National Naval Medical Center in Bethesda, MD. Following her end of obligated service as an active duty Naval Officer, she transferred her commission to the U.S. Public Health Service and began her FDA career.